These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31890938)

  • 1. Formulation development of chewable albendazole tablets with improved dissolution rate.
    Kimaro E; Tibalinda P; Shedafa R; Temu M; Kaale E
    Heliyon; 2019 Dec; 5(12):e02911. PubMed ID: 31890938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design.
    Tibalinda P; Sempombe J; Shedafa R; Masota N; Pius D; Temu M; Kaale E
    Heliyon; 2016 Dec; 2(12):e00207. PubMed ID: 27942608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability.
    Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N; Suwandecha T
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30897738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product.
    Chen Y; Feng T; Li Y; Du B; Weng W
    Pharm Dev Technol; 2017 Mar; 22(2):168-172. PubMed ID: 26654222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and optimization of a sublingual tablet formulation for physostigmine salicylate.
    Bolourchian N; Hadidi N; Foroutan SM; Shafaghi B
    Acta Pharm; 2009 Sep; 59(3):301-12. PubMed ID: 19819826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation.
    Khan A
    PLoS One; 2021; 16(12):e0261051. PubMed ID: 34882723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities.
    Hossain MS; Jahan S; Al Rezwan Rahman S; Rahman M; Kumar D; Paul S; Chandra Rajbangshi J
    Heliyon; 2023 Mar; 9(3):e14259. PubMed ID: 36938401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design.
    Soroush H; Ghorbani-Bidkorbeh F; Mortazavi SA; Mehramizi A
    Iran J Pharm Res; 2018; 17(4):1150-1163. PubMed ID: 30568675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate, cetirizine hydrochloride in combined pharmaceutical dosage form: a new era in novel drug delivery for pediatrics and geriatrics.
    Sharma D; Singh G; Kumar D; Singh M
    J Drug Deliv; 2015; 2015():640529. PubMed ID: 25810924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.
    Wardrop J; Jaber AB; Ayres JW
    Drug Dev Ind Pharm; 1998 Aug; 24(8):729-36. PubMed ID: 9876520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development and optimization of Ibuprofen tablets by direct compression method.
    Bushra R; Shoaib MH; Aslam N; Hashmat D; Ur-Rehman M
    Pak J Pharm Sci; 2008 Apr; 21(2):113-20. PubMed ID: 18390440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R; Naqvi BS; Shoaib MH; Rahim N
    Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK
    Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and optimization of orodispersible tablets of diazepam.
    Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
    AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh.
    Uddin MS; Mamun AA; Hossain MS; Asaduzzaman M; Sarwar MS; Rashid M; Herrera-Calderon O
    BMC Res Notes; 2017 May; 10(1):185. PubMed ID: 28558832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, optimization and characterization of chewable tablet containing synergistic combination of magnesium orotate dihydrate with cholecalciferol and menaquinone-7 for management of hyperglycemia and its pharmacokinetic study.
    Verma H; Garg R
    Magnes Res; 2021 May; 34(2):43-63. PubMed ID: 34463282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.